Biotech

All Articles

Aligos trumpets period 2 MASH win, lowering liver fat up to 46%

.Aligos Therapeutics is declaring a midstage succeed in metabolic-dysfunction connected steatohepati...

Basilea scores $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating brand-new antifungals has acquired a considerable increase fr...

Capricor sells Europe rights to late-stage DMD treatment for $35M

.Possessing already gathered up the USA civil liberties to Capricor Rehabs' late-stage Duchenne musc...

FDA junks adcomm for Applied's rare ailment medication

.After pushing the selection date for Applied Rehabs' metabolic disorder medicine govorestat, the FD...

Novo inks $600M NanoVation bargain to examine genetic medicines ex-liver

.Novo Nordisk is proceeding its push in to genetic medicines, consenting to pay NanoVation Therapeut...

Innovent links cytokine to intestines cancer cells actions

.Innovent Biologics has actually produced the instance that its checkpoint inhibitor-cytokine fusion...

Merck, Daiichi ADC attacks goal in stage 3 bronchi cancer research study

.A stage 3 test of Daiichi Sankyo and also Merck &amp Co.'s HER3-directed antibody-drug conjugate (A...

Rakovina grows artificial intelligence focus with collab to decide on cancer cells intendeds

.Five months after Rakovina Therapies pivoted towards expert system, the cancer-focused biotech has ...

Ascendis' dwarfism medication favorites in period 3, threatens BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting phase 3...

Despite ph. 3 skip, Alkeus finds course ahead for eye illness property

.Though Alkeus Pharmaceuticals' oral eye condition possession fell short to dramatically reduce geog...